Contract 36E79725D0053
Amgen USA Inc · Department Of Veterans Affairs · September 2, 2025
Amgen USA Inc was awarded a federal contract by Department Of Veterans Affairs on September 2, 2025 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 11, 2026. If all options are exercised, the contract could reach $15.38 million.
Contract details
- PIID
- 36E79725D0053
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 2, 2025
- Latest action
- March 11, 2026
Description
ADD NEW NDC FOR 420MG ON AMGEN NATIONAL CONTRACT FOR TRASTUZUMAB.
Modification timeline
-
March 11, 2026Mod P00004 · Other Administrative Action$0
-
January 20, 2026Mod P00003 · Other Administrative ActionADD NEW NDC FOR AMGEN NATIONAL CONTRACT FOR TRASTUZUMAB.$0
-
January 8, 2026Mod P00002 · Add Subcontracting PlanINCORPORATE 2026 AMGEN SUBCONTRACTING PLAN.$0
-
November 20, 2025Mod P00001 · Other Administrative ActionFCP 2026 PRICING FOR TRASTUZUMAB WITH AMGEN. ORDERING PERIOD IS NOV 15, 2025 THROUGH NOV 14, 2026 WITH FOUR ONE-YEAR OPTIONS.$0
-
September 2, 2025Base awardNEW AWARD FOR TRASTUZUMAB WITH AMGEN. ORDERING PERIOD IS NOV 15, 2025 THROUGH NOV 14, 2026 WITH FOUR ONE-YEAR OPTIONS.$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79725D0053?
Contract 36E79725D0053 is a federal contract awarded to Amgen USA Inc by Department Of Veterans Affairs on September 2, 2025 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract 36E79725D0053?
Amgen USA Inc won contract 36E79725D0053 from Department Of Veterans Affairs.
How much is contract 36E79725D0053 worth?
Contract 36E79725D0053 has obligated $0 to date but carries a potential ceiling of $15.38 million if fully funded and all options are exercised.